UCI, , Aigle, Switzerland.
Br J Sports Med. 2014 May;48(10):862-6. doi: 10.1136/bjsports-2014-093567. Epub 2014 Mar 19.
The introduction of the athlete's biological passport (ABP) has been a milestone in the fight against doping. The ABP is a collection of measurements of different biological parameters influenced by the administration of doping agents through the time and for each athlete. Two different modules have been developed and validated so far: the haematological module, which aims to identify enhancement of oxygen transport, including use of erythropoiesis-stimulating agents and any form of blood transfusion or manipulation, which became effective in 2010; and the steroidal module, which intends to detect the use of endogenous anabolic androgenic steroids when administered exogenously and other anabolic agents, which was introduced in 2014. Prior to the implementation of the haematological module, it is important to define an athlete's testing pool on whom to collect blood and/or urine in-competition and out-of-competition (for the steroidal module, this is irrelevant because all collected urine samples will be subjected to analysis for the steroidal variables) and to be compliant with the strict requirements of the World Anti-Doping Agency ABP Operating Guidelines. The established individual profile can be used either to target traditional antidoping tests (recombinant erythropoietins, or homologous blood transfusion tests for the haematological module; isotope ratio mass spectrometry (IRMS) for the steroidal module) or to support an antidoping rule violation due to the use of a forbidden substance or method. In this article, we present the experience of four major International Federations which have implemented an ABP programme, focusing on the haematological module. They constitute examples which could be followed by other antidoping organisations wishing to introduce this new, efficient and innovative antidoping tool.
运动员生物护照(ABP)的引入是打击兴奋剂斗争的一个里程碑。ABP 是一系列不同生物参数的测量值,这些参数受到兴奋剂管理的影响,并且针对每个运动员的情况进行测量。迄今为止,已经开发和验证了两个不同的模块:血液学模块,旨在识别氧气运输的增强,包括使用促红细胞生成素刺激剂和任何形式的输血或操纵,该模块于 2010 年生效;以及类固醇模块,旨在检测外源性使用内源性合成代谢雄激素类固醇和其他合成代谢剂,该模块于 2014 年引入。在实施血液学模块之前,重要的是要定义一个运动员的测试池,以便在比赛中和比赛外采集血液和/或尿液(对于类固醇模块,这是无关紧要的,因为所有采集的尿液样本都将接受类固醇变量的分析),并且要遵守世界反兴奋剂机构 ABP 操作指南的严格要求。建立的个人资料可以用于针对传统的反兴奋剂测试(血液学模块的重组促红细胞生成素或同源输血测试;类固醇模块的同位素比质谱法(IRMS)),或支持因使用禁用物质或方法而违反反兴奋剂规则。在本文中,我们介绍了四个主要国际联合会实施 ABP 计划的经验,重点介绍了血液学模块。它们构成了希望引入这种新的、高效和创新的反兴奋剂工具的其他反兴奋剂组织可以效仿的例子。